Rockwell Medical, Inc. Forecast, price target & analysts
Rockwell Medical, Inc. Target price 2025 - Analyst rating & recommendation
Rockwell Medical, Inc. Classifications & Recommendation:
Rockwell Medical, Inc. Price Target
| Target Price | $4.08 |
| Price | $0.79 |
| Potential |
415.09%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target Rockwell Medical, Inc. 2026 .
The average Rockwell Medical, Inc. target price is $4.08.
This is
415.09%
register free of charge
$5.25
562.80%
register free of charge
$3.03
282.53%
register free of charge
|
|
| A rating was issued by 8 analysts: 7 Analysts recommend Rockwell Medical, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Rockwell Medical, Inc. stock has an average upside potential 2026 of
415.09%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 101.49 | 69.59 |
| 21.39% | 31.43% | |
| EBITDA Margin | 2.75% | -4.14% |
| 143.95% | 250.60% | |
| Net Margin | -0.47% | -10.29% |
| 95.31% | 2,075.69% |
4 Analysts have issued a sales forecast Rockwell Medical, Inc. 2025 . The average Rockwell Medical, Inc. sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Rockwell Medical, Inc. EBITDA forecast 2025. The average Rockwell Medical, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Rockwell Medical, Inc. Analysts have issued a net profit forecast 2025. The average Rockwell Medical, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.02 | -0.21 |
| 94.44% | 950.00% | |
| P/E | negative | |
| EV/Sales | 0.28 |
4 Analysts have issued a Rockwell Medical, Inc. forecast for earnings per share. The average Rockwell Medical, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Rockwell Medical, Inc....
Current Rockwell Medical, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 24 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Dec 23 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 25 2024 |
| Rodman & Renshaw |
Locked
➜
Locked
|
Locked | Nov 14 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 11 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 04 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 24 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Dec 23 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 25 2024 |
|
Locked
Rodman & Renshaw:
Locked
➜
Locked
|
Nov 14 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 11 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 04 2024 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
